Recent Finacing
Recent Raise
Affineti Biologics develops tissue-adhering hybrid fusion proteins for non‑toxic antimicrobial dental therapies and diagnostics, targeting plaque, caries, periodontal disease with plans to expand to other mucosal infections.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor